期刊文献+

阳离子脂质体包裹bFGF作为免疫佐剂的制备工艺研究

bFGF Entraped in Cationic Liposomes as Adjuvant:Optimization of Technical Parameters
下载PDF
导出
摘要 目的考察阳离子脂质体包裹碱性成纤维细胞生长因子(bFGF)的制备工艺以及在小鼠体内的免疫效应。方法通过优化如脂质配方、药脂比、挤压次数、冻融次数以及孵化温度等各个工艺参数在保持bFGF高活性的前提下来提高bFGF的包封率。分别用bFGF阳离子脂质体、bFGF弗氏佐剂以及PBS分3组免疫4周龄Balb/c小鼠,连续免疫4次,ELISA测定各组小鼠血清的抗体滴度。结果优化得到脂质体配方为二油酰磷脂酰乙醇胺(DOPE)∶1,2-二油酰-3-三甲铵基丙烷(DOTAP)=2∶1;药脂比为7.5%;液氮速冻,4℃孵化60min,反复冻融6次;过膜挤压10次。通过工艺的改进,bFGF在脂质体中的包封率得到显著提高,达到50%。免疫实验中通过与弗氏佐剂免疫效果比较,阳离子脂质体作为佐剂产生的bFGF的抗体滴度为1∶3200,免疫效果比较令人满意。结论免疫实验中发现阳离子脂质体作为免疫佐剂,具有很好的佐剂效应。 Objective To test the immune efficiency of bFGF entraped in cationic liposomes as adiuvant in vivo. Methods The technical parameters on encapsulation were tested in each step to gain high encapsulation efficiencies, which included lipid composition, weight ratio of protein and lipids, liposome extrusion, and different conditions of freeze-thawing. The bFGF in cationic liposome, Freund's adjuvant, or PBS were injected (four times) to the four-week old Balb/c mice to test the immune responses. The serum antibody was measured by ELISA 13 days after each injection. Results Maximal encapsulation efficiency (about 50%) was achieved through optimized technical parameters. Cationic liposome demonstrated satisfied immune efficiency as adjuvant. Conclusion Cationic liposome is a safe and effective immunological adjuvant.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2008年第5期839-841,846,共4页 Journal of Sichuan University(Medical Sciences)
关键词 碱性成纤维细胞生长因子 免疫佐剂 阳离子脂质体 制备工艺 bFGF Adjuvant Cationic liposome Technical parameter
  • 相关文献

参考文献7

二级参考文献45

  • 1何敏,符华林,李英伦.兽用脂质体制剂的研究进展[J].中国兽药杂志,2004,38(9):33-37. 被引量:4
  • 2徐葛林.脂质体用作疫苗佐剂的研究进展[J].国外医学(预防.诊断.治疗用生物制品分册),1996,19(1):10-13. 被引量:11
  • 3沈咏舟,谢三星,魏建忠,曾明华.免疫佐剂和免疫调节剂的研究近况[J].吉林畜牧兽医,1996,18(4):24-26. 被引量:7
  • 4Bangham A D, Standish M M, Watkin J C ,et al. Diffussion of univalent inosacross the lamella of swollen phospholipids[J]. JMol Bio1,1965, 13:238-252.
  • 5Allison A C. Liposomes as immunological adjuvants[J]. Nature, 1974,252:252-254.
  • 6Bowersock T L, Martin S. Vaccine delivery to animals[J]. Advanced Drug Delivery Reviews, 1999,38(2):167-194.
  • 7Sessler W G,Jung G. Synthetic lipopeptides as novel adjuvants[J]. Res immunol, 1992,143 (5):548-553.
  • 8Eppstein D A, Fraser-Smith E B, Larsen M A, et al. Altered pharmacological properties of liposomes-associated human interferon-alpha[J]. J Virology, 1982,41:475.
  • 9Fraser-Smith E B, Eppstein D A, Larsen M A, et al. Protective effect of muramyldi peptide analogen capsula tedinor mixed with liposomes against Candida albicans infectlon[J]. Infect Immun, 1983,39:172-178.
  • 10O' Haagan D T, Mackichan M L, Singh M, et al. Recent dcvdoprnents in adjuvants for vaccines against infectious diseases[J]. Biomolecular Engineering, 2001, 18(3):69-85.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部